The award winning i-Lipo laser from Chromogenex offers you a safe and effective means to achieve immediate and measurable inch loss. i-Lipo uses low level laser technology (LLLT) to stimulate the body’s natural process for releasing its stored energy from adipose tissue, shrinking those fat cells and delivering the body shaping results you demand.

The human body stores excess calories from your diet in adipose tissue. When needed, those fat cells will break down their stored triglycerides into free fatty acids, glycerol and water, providing the body with energy during times of scarcity. That same metabolic process that is induced hormonally by the brain can also be triggered by low level laser energy delivered by i-Lipo.

i-Lipo is a revolutionary, non-invasive body shaping and cellulite reduction technology offering convenient, safe and pain free body contouring in as little as 20 minutes, without surgery and without downtime. This non-destructive approach to fat reduction can be used year-round on all skin types. i-Lipo treatments are passive and non-technique dependent, which means a constant manipulation of the device is not required. After the i-Lipo treatment pads are properly positioned, the technician is free to attend other office matters.

Clinical studies have confirmed the efficacy of the LLLT and the i-Lipo diode laser to deliver body shaping results. Two treatments per week for four weeks are recommended. All parts of the body can be treated where fat is stored, including the waistline, thighs, arms, leg and even under the chin. Patients typically report a 10% inch loss reduction following a treatment regimen.

i-Lipo is the first direct skin contact laser device designed for fat reduction and body contouring to receive FDA approval for circumferential reduction. Based on results from a recent double-blind, placebo-controlled, randomized study of 34 volunteers, the FDA found that over 70% of participants experienced significant inch loss, thus validating the use of i-Lipo to target specifically chosen anatomical areas for fat reduction. The results represented more than double the percentage difference for meeting significant results as defined by the FDA.